- Home
- DDI vs GKOS Comparison
DDI vs GKOS Comparison
Compare DDI & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DDI | GKOS |
|---|---|---|
| Founded | 2008 | 1998 |
| Country | South Korea | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 463.3M | 5.4B |
| IPO Year | 2021 | 2015 |
Fundamental Metrics
Financial Performance| Metric | DDI | GKOS |
|---|---|---|
| Price | $9.07 | $108.99 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 13 |
| Target Price | $19.25 | ★ $123.62 |
| AVG Volume (30 Days) | 46.1K | ★ 860.2K |
| Earning Date | 11-10-2025 | 10-29-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 0.12 | N/A |
| EPS | ★ 2.30 | N/A |
| Revenue | $346,122,000.00 | ★ $469,820,000.00 |
| Revenue This Year | $16.48 | $31.15 |
| Revenue Next Year | $7.89 | $24.15 |
| P/E Ratio | $3.93 | ★ N/A |
| Revenue Growth | 1.07 | ★ 30.38 |
| 52 Week Low | $8.09 | $73.16 |
| 52 Week High | $12.65 | $163.71 |
Technical Indicators
Market Signals| Indicator | DDI | GKOS |
|---|---|---|
| Relative Strength Index (RSI) | 49.97 | 70.89 |
| Support Level | $9.02 | $105.88 |
| Resistance Level | $9.43 | $110.87 |
| Average True Range (ATR) | 0.21 | 3.39 |
| MACD | -0.01 | -0.04 |
| Stochastic Oscillator | 31.76 | 80.77 |
Price Performance
Historical ComparisonAbout DDI DoubleDown Interactive Co. Ltd. American Depository Shares
DoubleDown Interactive Co Ltd is a developer and publisher of digital games on mobile and web-based platforms. The company is the creator of multi-format interactive entertainment experiences for casual players. The company's operating segments include the social casino games segment and the iGaming segment. The company generates the majority of its revenue from social casino games. Geographically, the company generates the majority of its revenue from the United States.
About GKOS Glaukos Corporation
Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.